Wesley Yip

559 total citations
44 papers, 233 citations indexed

About

Wesley Yip is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wesley Yip has authored 44 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 17 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Wesley Yip's work include Bladder and Urothelial Cancer Treatments (21 papers), Urinary and Genital Oncology Studies (11 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Wesley Yip is often cited by papers focused on Bladder and Urothelial Cancer Treatments (21 papers), Urinary and Genital Oncology Studies (11 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Wesley Yip collaborates with scholars based in United States, Australia and Spain. Wesley Yip's co-authors include Giovanni Cacciamani, Clayton Lau, Timothy G. Wilson, David Josephson, Nora Ruel, Kevin Chan, Robert R. Torrey, Monish Aron, Nima Nassiri and Fiona Stapleton and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wesley Yip

35 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wesley Yip United States 9 126 64 57 38 22 44 233
R. Christopher Doiron Canada 11 89 0.7× 45 0.7× 175 3.1× 18 0.5× 18 0.8× 33 319
Marcelo Thiel Brazil 8 120 1.0× 28 0.4× 79 1.4× 20 0.5× 7 0.3× 23 288
Sang Jin Yoon South Korea 13 93 0.7× 81 1.3× 272 4.8× 18 0.5× 124 5.6× 43 430
Wendy A. Robson United Kingdom 8 73 0.6× 73 1.1× 163 2.9× 17 0.4× 9 0.4× 11 244
Ivan Matteo Tavolini Italy 9 171 1.4× 83 1.3× 20 0.4× 23 0.6× 34 1.5× 15 276
Aldo Franco De Rose Italy 10 169 1.3× 52 0.8× 189 3.3× 10 0.3× 25 1.1× 29 328
Andrea Baudo Italy 9 92 0.7× 47 0.7× 45 0.8× 13 0.3× 25 1.1× 39 206
Tae Beom Kim South Korea 10 42 0.3× 59 0.9× 144 2.5× 10 0.3× 123 5.6× 37 317
Koenraad van Renterghem Belgium 11 158 1.3× 99 1.5× 168 2.9× 9 0.2× 40 1.8× 68 417
Yuen Shan Wong Hong Kong 12 213 1.7× 76 1.2× 33 0.6× 6 0.2× 31 1.4× 24 304

Countries citing papers authored by Wesley Yip

Since Specialization
Citations

This map shows the geographic impact of Wesley Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley Yip more than expected).

Fields of papers citing papers by Wesley Yip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley Yip. The network helps show where Wesley Yip may publish in the future.

Co-authorship network of co-authors of Wesley Yip

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley Yip. A scholar is included among the top collaborators of Wesley Yip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley Yip. Wesley Yip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yip, Wesley, et al.. (2025). Urothelial carcinoma: Perioperative considerations from top to bottom. CA A Cancer Journal for Clinicians. 75(6). 528–551. 1 indexed citations
2.
Budhu, Sadna, Kwanghee Kim, Wesley Yip, et al.. (2024). Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model. Frontiers in Oncology. 14. 1405486–1405486.
3.
Yip, Wesley & A. Ari Hakimi. (2023). Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review. SHILAP Revista de lepidopterología. 4(4). 287–292.
4.
Katims, Andrew, Christopher Gaffney, Wesley Yip, et al.. (2023). Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 41(10). 433.e19–433.e24. 5 indexed citations
5.
Chu, Carissa, Jessica Chen, Karissa Whiting, et al.. (2023). MP63-08 CLINICAL AND GENOMIC RISK FEATURES OF HIGH GRADE T1 NON-MUSCLE INVASIVE BLADDER CANCER. The Journal of Urology. 209(Supplement 4).
6.
Ghoreifi, Alireza, Michael Chevinsky, Akbar Ashrafi, et al.. (2022). Tips and Tricks for Robotic Retroperitoneal Lymph Node Dissection in Testicular Cancer. Videourology. 36(3). 1 indexed citations
7.
Yip, Wesley, Akbar Ashrafi, Mihir Desai, et al.. (2022). An Enhanced Recovery After Surgery protocol for robotic-assisted laparoscopic nephrectomies utilizing a quadratus lumborum block. Journal of Robotic Surgery. 16(6). 1383–1389. 3 indexed citations
8.
Zhang, Michael, et al.. (2021). Robotic Intracorporeal Ileal Conduit Urinary Diversion Technique. Journal of Endourology. 35(2_suppl). S–116.
9.
10.
Ashrafi, Akbar, Wesley Yip, André Berger, et al.. (2021). Implementation of a multimodal opioid-sparing enhanced recovery pathway for robotic-assisted radical prostatectomy. Journal of Robotic Surgery. 16(3). 715–721. 4 indexed citations
11.
Dziadziuszko, Rafał, Fabrice André, Wesley Yip, et al.. (2020). 1193P Clinical validity of FoundationOne liquid CDx (F1L CDx) assay as an aid in selecting patients for treatment with entrectinib. Annals of Oncology. 31. S785–S786. 4 indexed citations
12.
Cheng, Kai, Wesley Yip, Luis G. Medina, et al.. (2020). Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions. World Journal of Urology. 39(5). 1521–1529.
13.
Ashrafi, Akbar, et al.. (2020). Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer. Urology Case Reports. 32. 101229–101229. 6 indexed citations
14.
Cacciamani, Giovanni, Alessandro Tafuri, Atsuko Iwata, et al.. (2020). Quality Assessment of Intraoperative Adverse Event Reporting During 29 227 Robotic Partial Nephrectomies: A Systematic Review and Cumulative Analysis. European Urology Oncology. 3(6). 780–783. 11 indexed citations
15.
Aron, Monish, et al.. (2020). Neoadjuvant therapy in high-risk prostate cancer. Indian Journal of Urology. 36(4). 251–251. 7 indexed citations
16.
Yip, Wesley, Giovanni Cacciamani, & Sumeet Bhanvadia. (2020). Disparities in Bladder Cancer Outcomes Based on Key Sociodemographic Characteristics. Current Urology Reports. 21(6). 24–24. 3 indexed citations
17.
Yip, Wesley, Akbar Ashrafi, & Siamak Daneshmand. (2019). High-grade T1 Urothelial Carcinoma: Where Do We Stand?. Current Urology Reports. 20(12). 79–79. 5 indexed citations
18.
Yip, Wesley, Saum Ghodoussipour, & Sumeet Bhanvadia. (2018). Acute lung injury following penile ischemia and reperfusion. Urology Case Reports. 22. 23–24. 1 indexed citations
20.
Long, Jennifer, et al.. (2010). Risk Factors for Physical Discomfort in Australian Optometrists. Optometry and Vision Science. 88(2). 317–326. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026